RECOMBINANT PROUROKINASE IN ACUTE ISCHEMIC STROKE WITHIN 4.5 HOURS OF STROKE ONSET TRIAL-2 (PROST-2): A PHASE 3, MULTI-CENTRE, OPEN-LABEL, BLINDED-ENDPOINT, RANDOMISED CONTROLLED, NON-INFERIORITY TRIAL

被引：0
|
作者：
Li, S. [1 ]
Gu, H. [1 ]
Feng, B. [1 ]
Wang, Y. [1 ]
机构：
[1] Beijing Tiantan Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O126 / #3
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [31] A multi-centre open-label randomised non-inferiority trial comparing watchful waiting to antibiotic treatment for acute otitis media without perforation in low-risk urban Aboriginal and Torres Strait Islander children (the WATCH trial): study protocol for a randomised controlled trial
    Penelope Abbott
    Hasantha Gunasekera
    Amanda Jane Leach
    Deborah Askew
    Robyn Walsh
    Kelvin Kong
    Federico Girosi
    Chelsea Bond
    Peter Morris
    Sanja Lujic
    Wendy Hu
    Tim Usherwood
    Sissy Tyson
    Geoffrey Spurling
    Markeeta Douglas
    Kira Schubert
    Shavaun Chapman
    Nadeem Siddiqui
    Reeion Murray
    Keitha Rabbitt
    Bobby Porykali
    Cheryl Woodall
    Tina Newman
    Jennifer Reath
    Trials, 17
  • [32] Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial (vol 401, pg 645, 2023)
    Wang, Y.
    Li, S.
    Pan, Y.
    LANCET, 2023, 401 (10382): : 1078 - 1078
  • [33] Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial (vol 604, pg 645, 2023)
    Wang, Y.
    Li, S.
    Pan, Y.
    LANCET, 2020, 401 (10382): : 1078 - 1078
  • [34] Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
    Welsche, Sophie
    Mrimi, Emmanuel C.
    Hattendorf, Jan
    Huerlimann, Eveline
    Ali, Said M.
    Keiser, Jennifer
    LANCET INFECTIOUS DISEASES, 2023, 23 (03): : 331 - 340
  • [35] Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
    Cohen, Hannah
    Hunt, Beverley J.
    Efthymiou, Maria
    Arachchillage, Deepa R. J.
    Mackie, Ian J.
    Clawson, Simon
    Sylvestre, Yvonne
    Machin, Samuel J.
    Bertolaccini, Maria L.
    Ruiz-Castellano, Maria
    Muirhead, Nicola
    Dore, Caroline J.
    Khamashta, Munther
    Isenberg, David A.
    Lancet Haematology, 2016, 3 (09): : E426 - E436
  • [36] Tenecteplase versus alteplase for acute stroke within 4<middle dot>5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
    Muir, Keith W.
    Ford, Gary A.
    Ford, Ian
    Wardlaw, Joanna M.
    McConnachie, Alex
    Greenlaw, Nicola
    Mair, Grant
    Sprigg, Nikola
    Price, Christopher, I
    MacLeod, Mary Joan
    Dima, Sofia
    Venter, Marius
    Zhang, Liqun
    O'Brien, Eoin
    Sanyal, Ranjan
    Reid, John
    Sztriha, Laszlo K.
    Haider, Syed
    Whiteley, William N.
    Kennedy, James
    Perry, Richard
    Lakshmanan, Sekaran
    Chakrabarti, Annie
    Hassan, Ahamad
    Marigold, Richard
    Raghunathan, Senthil
    Sims, Don
    Bhandari, Mohit
    Wiggam, Ivan
    Rashed, Khalid
    Douglass, Chris
    LANCET NEUROLOGY, 2024, 23 (11): : 1087 - 1096
  • [37] Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial
    Nyang'wa, Bern-Thomas
    Berry, Catherine
    Kazounis, Emil
    Motta, Ilaria
    Parpieva, Nargiza
    Tigay, Zinaida
    Moodliar, Ronelle
    Dodd, Matthew
    Solodovnikova, Varvara
    Liverko, Irina
    Rajaram, Shakira
    Rassool, Mohammed
    McHugh, Timothy
    Spigelman, Melvin
    Moore, David A.
    Ritmeijer, Koert
    du Cros, Philipp
    Fielding, Katherine
    LANCET RESPIRATORY MEDICINE, 2024, 12 (02): : 117 - 128
  • [38] A multi-centre open-label randomised non inferiority trial comparing watchful waiting to antibiotic treatment for acute otitis media without perforation in low-risk urban Aboriginal and Torres Strait Islander children (the WATCH trial): study protocol for a randomised controlled trial
    Abbott, Penelope
    Gunasekera, Hasantha
    Leach, Amanda Jane
    Askew, Deborah
    Walsh, Robyn
    Kong, Kelvin
    Girosi, Federico
    Bond, Chelsea
    Morris, Peter
    Lujic, Sanja
    Hu, Wendy
    Usherwood, Tim
    Tyson, Sissy
    Spurling, Geoffrey
    Douglas, Markeeta
    Schubert, Kira
    Chapman, Shavaun
    Siddiqui, Nadeem
    Murray, Reeion
    Rabbitt, Keitha
    Porykali, Bobby
    Woodall, Cheryl
    Newman, Tina
    Reath, Jennifer
    TRIALS, 2016, 17
  • [39] Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial
    Olthuis, Susanne G. H.
    Pirson, F. Anne, V
    Pinckaers, Florentina M. E.
    Hinsenveld, Wouter H.
    Nieboer, Daan
    Ceulemans, Angelique
    Knapen, Robrecht R. M. M.
    Robbe, M. M. Quirien
    Berkhemer, Olvert A.
    van Walderveen, Marianne A. A.
    Nijeholt, Geert J. Lycklama a
    Uyttenboogaart, Maarten
    Schonewille, Wouter J.
    van der Sluijs, P. Matthijs
    Wolff, Lennard
    van Voorst, Henk
    Postma, Alida A.
    Roosendaal, Stefan
    van der Hoorn, Anouk
    Emmer, Bart J.
    Krietemeijer, Menno G. M.
    van Doormaal, Pieter-Jan
    Roozenbeek, Bob
    Goldhoorn, Robert-Jan B.
    Staals, Julie
    Ridder, Inger R. de
    van der Leij, Christiaan
    Coutinho, Jonathan M.
    van der Worp, H. Bart
    Lo, Rob T. H.
    Bokkers, Reinoud P. H.
    Dijk, Ewoud Ivan
    Boogaarts, Hieronymus
    Wermer, Marieke J. H.
    van Es, Adriaan C. G. M.
    van Tuijl, Julia H.
    Kortman, Hans G. J.
    Gons, Rob A. R.
    Yo, Lonneke S. F.
    Vos, Jan-Albert
    Laat, Karlijn F. de
    van Dijk, Lukas C.
    van den Wijngaard, Ido R.
    Hofmeijer, Jeannette
    Martens, Jasper M.
    Brouwers, Paul J. A. M.
    Bulut, Tomas
    Remmers, Michel J. M.
    de Jong, Thijs E. A. M.
    den Hertog, Heleen M.
    LANCET, 2023, 401 (10385): : 1371 - 1380
  • [40] Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial
    Maggio, Aurelio
    Kattamis, Antonis
    Felisi, Mariagrazia
    Reggiardo, Giorgio
    El-Beshlawy, Amal
    Bejaoui, Mohamed
    Sherief, Laila
    Christou, Soteroula
    Cosmi, Carlo
    Della Pasqua, Oscar
    Del Vecchio, Giovanni Carlo
    Filosa, Aldo
    Cuccia, Liana
    Hassab, Hoda
    Kreka, Manika
    Origa, Raffaella
    Putti, Maria Caterina
    Spino, Michael
    Telfer, Paul
    Tempesta, Bianca
    Vitrano, Angela
    Tsang, Yu Chung
    Zaka, Ariana
    Tricta, Fernando
    Bonifazi, Donato
    Ceci, Adriana
    LANCET HAEMATOLOGY, 2020, 7 (06): : E469 - E478
12345